Verification of the cardioprotective effect of ARNI on hemodialysis patients with heart disease
Not Applicable
Recruiting
- Conditions
- Hemodialysis patients with chronic heart failure
- Registration Number
- JPRN-UMIN000052905
- Lead Sponsor
- Inoue Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have difficulty undergoing dialysis due to low blood pressure, patients with dementia, and patients who were unable to consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Compare changes in cardiac function in the ARNI administration group before and 12 months after initiation of ARNI with the control group.
- Secondary Outcome Measures
Name Time Method Changes in NTproBNP, HANP, and blood pressure before starting ARNI, 1 month, 3 months, 6 months, and 12 months after starting ARNI